Navigation Links
Toxic Neglect: Mutual Funds Opposing Shareholder Resolutions on Chemicals in Products Ignore Financial Risks to Shareholders
Date:2/28/2008

Turning a Blind Eye to Risk: Fidelity, American Funds, T Rowe Price, ING, Morgan Stanley, MassMutual; Some Encouraging Signs Seen at TIAA-CREF and ISS

WASHINGTON, Feb. 28 /PRNewswire/ -- More than three out of four major mutual fund families in the United States -- 40 out of 52 (or 77 percent) -- routinely opposed or abstained from voting on toxic chemical shareholder resolutions in 2006 and 2007, according to a major new report today from The Investor Environmental Health Network (IEHN) and The Rose Foundation for Communities and the Environment.

The IEHN/Rose report, Mutual Neglect: How the Largest Institutions in the Stock Market Ignore Health Problems and Financial Threats Stemming From Toxic Product Liabilities draws on data from a total of 64 families of mutual funds casting votes in 2006 and 2007 on shareholder resolutions. Only 195 votes were cast in favor and 1,752 were cast against shareholder resolutions addressing issues such as pesticides and asthma and toxic chemicals in children's toys and cosmetics. Entire fund families such as ING (213 "no" votes), Morgan Stanley (90 "no" votes), and T Rowe Price (110 "no" votes) voted against ALL resolutions. Fidelity and American Funds also did not support any resolutions. Vanguard abstained 157 times, maintaining that "social policy issues" such as toxic chemicals in products are "ordinary business" best handled by company management.

Ironically, the report finds that funds of two financial companies that market both mutual funds and health insurance -- John Hancock and MassMutual -- did not support resolutions at Dow Chemical Company requesting an assessment of links between the company's pesticide products and asthma. Morgan Stanley's mutual funds also voted against this resolution, even though Morgan Stanley contributed $60 million to the Morgan Stanley Children's Hospital in 2003, whose services include a facility to treat childhood asthma.

Tim Little, executive director, The Rose Foundation and a contributor to the report said: "Even as more and more evidence mounts of the danger posed to the public's health and the wealth of shareholders by toxic chemicals in products, America's largest fund families are continuing to turn a blind eye to the problem. The only problem for shareholders here is that denial is no investment strategy. When it comes to mutual funds investing in companies with toxic products, denial is inevitably going to be a prescription for financial disaster."

Richard Liroff, executive director of IEHN, commented: "Mutual fund investors are really shareholder/consumers. Their investment gains may be offset by the costs they incur from chemicals in everyday products. So their return on investment may be lower or even negative, if one counts their health costs from exposures to chemicals in products made by their portfolio companies."

According to the report, toxic chemicals in products can have a sizeable business impact of the sort that hurts the bottom lines of mutual funds and their shareholders. Examples include recall costs, litigation expenses and a sharp stock price drop at Thomas the Tank Engine manufacturer RC2; reduced sales growth in beauty products at Procter & Gamble because of allegations in China of contaminated skin cream; litigation and civil penalty costs at DuPont over the PFOA used to manufacture Teflon coatings; and reputational damage at Wal-Mart and other retailers over recalled baby bibs and lunch boxes.

ENCOURAGING SIGNS AND RECOMMENDATIONS

Despite the predominately gloomy picture it paints, the report finds several reasons for hope.

-- First, are revisions to TIAA-CREF's proxy voting guidelines in 2007. The $430 billion fund family's new proxy voting guidelines section on "Product Responsibility" declares that TIAA-CREF will generally support reasonable shareholder resolutions seeking disclosure of the safety and impact of company products on customers and communities. TIAA-CREF funds supported all toxic chemical resolutions at their portfolio companies in 2007.

-- Second, are new proxy voting guidelines adopted by government employee pension funds in Connecticut, New York City, and Maryland that also address product stewardship issues.

-- Third, are recent revisions to the proxy voting guidelines of Institutional Shareholder Services, the largest proxy voting advisory service in the United States, recognizing the need for companies to better address toxic chemicals in their supply chains.

The report makes 3 recommendations to the mutual fund industry:

-- Adopt proxy voting guidelines similar to ISS or TIAA-CREF.

-- Follow TIAA-CREF's lead and survey their participants' opinions on responsible investing, including shareholder activism.

-- Fund trustees should explore issues of links between toxic chemicals and financial risk with their investment managers and consultants.

The report also urges investors in mutual funds to contact their funds' investor services department to ask that funds adopt proxy voting guidelines addressing these issues

Many mutual funds seem to be ignoring the business case behind shareholder resolutions seeking to reduce toxics in consumer products. What's worse, many mutual funds also seem to be voting against their shareholders' health. Funds that continue to turn a tin ear towards toxics may find themselves losing market share in the very competitive mutual fund marketplace.

For the full report, go to http://iehn.org/publications.reports.mutualfunds.php on the Web.

METHODOLOGY

IEHN's analysis of mutual fund voting draws on a database of voting behavior of 1,400 funds in 64 mutual fund families compiled by Jackie Cook of Boardmap Research, Vancouver, Canada. This is an extensive but not exhaustive database of more than 8.5 million voting decisions by most of the largest funds from most of the largest U.S. fund groups over four years. The data and data summaries are available on-line at:

http://www.fundvotes.com/IEHN/Toxics_FundVoteResults_2006-2007.xls.

ABOUT THE GROUPS

The Investor Environmental Health Network (http://www.iehn.org) is a collaboration of investment managers encouraging companies to adopt "safer chemicals" policies for products, to enhance shareholder value. IEHN participants manage more than $41 billion in assets.

The Rose Foundation for Communities and the Environment has been recognized nationally for innovative shareholder advocacy campaigns and for its research into the correlation between corporate environmental and financial performance. Its petition to the U.S. Securities and Exchange Commission seeking more robust disclosure of environmental risk has been endorsed by institutional investors collectively representing more than $1 trillion in assets under management.


'/>"/>
SOURCE Investor Evironmental Health Network (IEHN), Washington,D.C.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Federal toxics disclosure law could help inform public of nanotechnology risks
2. AAP Calls for an End to Toxic Tobacco Content in Hollywood Movies
3. U.S. Seeks to Limit Animal Testing of Toxic Chemicals
4. Baby Bottles Leach Toxic Chemical, According to New U.S. and Canadian Study
5. Akela Pharma receives letter from the FDA regarding its pre-clinical toxicology studies for Fentanyl TAIFUN(R)
6. Wild Childs Quit Nits Offers a Safe, Natural Alternative to Current Toxic Head Lice Products
7. A promising new approach to cadmium induced hepatoxicity: Cytoprotective effect of midkine
8. Inverness Medical Innovations to Acquire Redwood Toxicology Laboratory
9. Another smart cancer drug can have toxic effects on the heart
10. Once-Daily Exjade(R) Shown to Remove Toxic Iron From the Heart and Liver, According to Data Presented at ASH
11. ABA Conference in Chicago Provides Litigators First Look at DNA Technology That Can Save Millions in Workers Comp and Toxic Tort Cases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2017)... , ... August 18, 2017 , ... ... Administration Reauthorization Act of 2017, legislation that provides for greater public access to ... moderate hearing loss to access OTC hearing aids without being seen by a ...
(Date:8/19/2017)... ... August 19, 2017 , ... ... of breastfeeding mothers. These illustrations show the diversity of the breastfeeding mothers, ... a wide range of sizes. These illustrations are also available on tote bags, ...
(Date:8/19/2017)... ... August 19, 2017 , ... Physician Partners ... Orlando location as an interventional pain management physician. He brings a wealth of ... of migraine headaches, and significant experience in spinal cord stimulation for chronic pain. ...
(Date:8/18/2017)... ... ... More than 20,000 pairs of shoes made their way across the Atlantic ... that conjoined the passions of an NBA star, a Liberty University student, and an ... will save lives from the rampant infections transmitted through the soil. , AMERICAN SOLES ...
(Date:8/18/2017)... ... August 18, 2017 , ... Mediaplanet today announces the ... healthy lifestyles and highlighting the importance of proactive eye and ear health. The ... the latest innovations in hearing aid technology. , In this issue, the ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... International plc (NASDAQ: ENDP ) today announced that ... U.S. mesh product liability claims and that it is ... claims at reasonable values. Under the agreements, Endo will ... 2017 and continuing through the fourth quarter of 2019. ... Company intends to increase its mesh product liability accrual ...
(Date:8/4/2017)... CINCINNATI , Aug. 3, 2017  Agragen, ... science company active in the biopharmaceutical, nutraceutical, and ... its development of its lead drug candidates, AGR131.  ... a proinflammatory cytokine from the blood of patients ... psoriasis, and inflammatory bowel disease. ...
(Date:8/2/2017)... 2017 Fenita J. Caldwell ... Pinnacle Lifetime Professional in the Field of Healthcare. ... Turing Pharmaceuticals, AG. Her skills and areas of ... ... of experience as a highly successful sales specialist ...
Breaking Medicine Technology: